PANACEABIO — Panacea Biotec Share News
0.000.00%
Last trade - 00:00- IN₹19.08bn
- IN₹17.91bn
- IN₹6.40bn
Media: Adar Poonawalla exits Panacea Biotec; sells entire stake for 1.18 bln rupees - PTI in Mint
Brief: Panacea Biotec Files Suit To Restrain Sanofi Healthcare From Marketing Fully Liquid Hexavalent Vaccine
Media: Indian drug firm Panacea sues Sanofi over vaccine for kids - Times of India
Rdif's India Partners Rise After Sputnik V Covid: 19 vaccine gets regulatory OK
India's Panacea Biotec jumps 20%; co to produce 100 mln Sputnik V doses annually
India's Panacea Biotec to produce 100 mln Sputnik V doses annually -RDIF
Brief: India's Panacea Biotec Dec-Qtr Consol Net Loss After Tax Widens
Media: India's Panacea Biotec, RDIF in advanced talks to make Sputnik V vaccine - Mint
Brief: Panacea Biotec Informs Of Fire Incident At Pharmaceutical Formulations Facility Of Unit
Brief: Panacea Biotec Posts Smaller Loss in Sept-Quarter
Brief: India's Panacea Biotec Completes Phase I/II Study Of Dengue Vaccine Candidate
Brief: India's Panacea Biotec Says Real Estate Unit Demerger Approved By NCLT
Brief: Panacea Biotec June Quarter Consol Loss Widens
Indian drugmaker Biological E. to make substance used in J&J's potential COVID-19 vaccine
Panacea Biotec aims to make 1 bln doses of COVID-19 vaccine candidate in 2022 (updated)
Panacea Biotec sees production of 1 bln doses of COVID-19 vaccine candidate in 2022
Brief: Panacea Biotec March-Quarter Consol Loss Narrows
Brief: Panacea Biotec Says Refana To Have Option To Invest $10 Mln In Co Under MoU
India's Panacea Biotec soars 20% as it partners U.S. firm for potential COVID-19 vaccine